Floatz logo

Benzeneethanamine, N-ethyl-?-methyl-4-(trifluoromethyl)-, hydrochloride, (±)-

Inv Dup(15) Encephalopathy

Hospital Ruber InternacionalSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Inv Dup(15) Encephalopathy cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Benzeneethanamine, N-ethyl-?-methyl-4-(trifluoromethyl)-, hydrochloride, (±)- is also rated in:

Dravet syndromeDormant
BBB
Indicative ·
78 / 100
View asset →
Lennox-Gastaut syndromeDormant
BB
Indicative ·
69 / 100
View asset →
cognitive disorderDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →